| Autor: |
Charous SJ; Department of Otolaryngology, Loyola University Medical Center, 3633 West Lake Ave., Suite 300, Glenview, IL 60026, USA. scharous@comcast.net, Comella CL, Fan W |
| Jazyk: |
angličtina |
| Zdroj: |
Ear, nose, & throat journal [Ear Nose Throat J] 2011 Feb; Vol. 90 (2), pp. E9. |
| DOI: |
10.1177/014556131109000210 |
| Abstrakt: |
The objective of this study was to investigate quality-of-life outcomes in patients with jaw-opening oromandibular dystonia who had received treatment with botulinum neurotoxin injections. The Glasgow Benefit Inventory (GBI) was used as a post-intervention questionnaire to measure patient benefit. Twenty-five questionnaires were sent to patients. Of the 12 patients who returned the form (48% response rate), the mean scores for the general GBI subscore (p = 0.001), the social support GBI subscore (p = 0.031), and the physical health GBI subscore (p = 0.002) demonstrated statistically significant benefit from the injections. No scores demonstrated a negative impact. Botulinum neurotoxin injections were demonstrated to benefit the quality of life in patients suffering from jaw-opening oromandibular dystonia. |
| Databáze: |
MEDLINE |
| Externí odkaz: |
|
